Montreal, QC – A receptor for the dopamine neurotransmitter promotes growth and spread of pancreatic cancer – and schizophrenia drugs, which block the function of this receptor, slowed tumour growth and metastatic spread in mice, according to researchers at McGill…
The post Schizophrenia medication inhibits pancreatic cancer appeared first on Lab Product News.